Vyvanse Approved for Adolescent ADHD - Drugs.com MedNews
Links shared publicly online about this topic.
- 725total visits
Vyvanse Approved for Adolescent ADHD - Drugs.com MedNews
View full resource at drugs.com
Tags: ADHD, ADHD Medication, Disease and Condition, Drug, FDA, Vyvanse
Most Recently Shared on November 15, 2010 at 6:11 pm By:
Vyvanse Approved for Adolescent ADHD: MONDAY, Nov. 15 -- Vyvanse (lisdexamfetamine dimesylate) capsules ha... http://bit.ly/9roJY5 #drug
Shire's ADHD Drug Vyvanse Gets Approval In Canada For Adolescents, Adults
rttnews.com — “Drug maker Shire plc (SHP.L, SHPGY), Wednesday said it has received Health Canada approval for Vyvanse, for the treatment of attention deficit hyperactivity disorder in adolescents and adults.” View full resource at rttnews.com
Most Recently Shared on February 2, 2011 at 8:23 pm By:
Peter H Brown Doctor and Psychologist
Shire's ADHD Drug Vyvanse Gets Approval In Canada For Adolescents, Adults http://bit.ly/gUSS8a #ADHD
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
drugs.com — “Vyvanse (lisdexamfetamine) is used to treat ADHD. Includes Vyvanse side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 15, 2010 at 11:03 pm By:
Drugs and Devices OW OW Health
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents: ... http://bit.ly/c1yPph #drug
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
drugs.com — “Vyvanse (lisdexamfetamine) is used to treat ADHD. Includes Vyvanse side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 15, 2010 at 10:57 pm By:
FDA Approves Vyvanse (lisdexamfetamine dimesylate) for the Treatment of ADHD in Adolescents - http://bit.ly/9kNj6A
Vyvanse gains indication for ADHD in adolescents - MPR
empr.com — “The FDA has approved Vyvanse (lidexamfetamine dimesylate capsules, from Shire) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents 13--17 years of age.” View full resource at empr.com
Most Recently Shared on November 15, 2010 at 4:34 pm By:
MPR News: Vyvanse gains indication for ADHD in adolescents: The FDA has approved Vyvanse (lidexamfetamine dimesy... http://bit.ly/9e4SlI
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD i” View full resource at news-medical.net
Most Recently Shared on November 15, 2010 at 3:49 pm By:
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents: Shire plc, the global specialty bi... http://bit.ly/a0SfMQ
Vyvanse gains indication for ADHD in adolescents - ONA
oncologynurseadvisor.com — “The FDA has approved Vyvanse (lidexamfetamine dimesylate capsules, from Shire) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents 13--17 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 15, 2010 at 3:38 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Vyvanse gains indication for ADHD in adolescents http://goo.gl/fb/EQzPw
Advertisement
